Home LiteratureArticle Details
PMID: 12958069 Published · ppublish English Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy.

Blood ·Vol. 103 ·No. 3 ·2004-02-01 ·Pages 966-72

Harari A, Petitpierre S, Vallelian F, Pantaleo G

Abstract

HIV-1- and cytomegalovirus (CMV)-specific CD4 T-cell-mediated antiviral immunity was evaluated by assessing the frequency of interleukin 2 (IL-2)- and interferon gamma (IFN-gamma)-secreting cells following antigen-specific stimulation in blood and lymph node. HIV-1-infected subjects with progressive disease at early stage of infection with no previous history of antiretroviral therapy (ART), subjects with nonprogressive disease, and HIV-negative subjects were studied. On the basis of the ability to secrete IL-2 and IFN-gamma, 3 functionally distinct populations of CD4 T cells were identified: (1) IL-2-secreting cells; (2) IL-2/IFN-gamma-secreting cells; and (3) IFN-gamma-secreting cells. CMV-specific CD4 T cells were almost equally distributed within the 3 functionally distinct cell populations in the 3 study groups as well as HIV-1-specific CD4 T cells in subjects with nonprogressive disease. However, a skewing toward IFN-gamma-secreting cells (70% of HIV-1-specific CD4 T cells) was observed in subjects with progressive disease, and IL-2- and IL-2/IFN-gamma-secreting cells were almost absent. The frequencies of IL-2- and of IL-2/IFN-gamma-secreting HIV-1-specific CD4 T cells were negatively correlated with the levels of viremia. Interestingly, prolonged ART was able to correct the skewed representation of different populations of HIV-1-specific CD4 T cells but was associated with only a partial recovery of IL-2-secreting cells. These results indicate that the composition of the pool of functionally distinct virus-specific CD4 T cells is important for virus control.

MeSH Terms
Anti-HIV Agents/therapeutic use CD4 Lymphocyte Count CD4-Positive T-Lymphocytes/drug effects,immunology Cytomegalovirus/immunology HIV Infections/drug therapy,immunology HIV-1 Humans Interferon-gamma/biosynthesis Interleukin-2/biosynthesis Prospective Studies T-Lymphocyte Subsets/drug effects,immunology
Chemicals
Anti-HIV Agents Interleukin-2 Interferon-gamma
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Harari Alexandre
Laboratory of AIDS Immunopathogenesis, Division of Immunology and Allergy, Centre Hospitalier Universitaire Vaudois, Rue Bugnon, 1011 Lausanne, Switzerland.
Petitpierre Stéphanie
Vallelian Florence
Pantaleo Giuseppe
Article Info
Journal
Blood
Abbr.
Blood
ISSN
0006-4971
Published
2004-02-01
Epub
2003-00-04
Pages
966-72
Language
English
Region
United States
NLM ID
7603509
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com